Trial Profile
A Randomized, Double Blind, Placebo-Controlled Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Jun 2012
Price :
$35
*
At a glance
- Drugs Darbepoetin alfa (Primary)
- Indications Chemotherapy-induced anaemia
- Focus Therapeutic Use
- Sponsors Amgen
- 31 Mar 2009 New trial record